The FDA shortage list still showed lisdexamfetamine capsules in shortage on 13 October 2026
FDA first posted lisdexamfetamine capsules as a shortage on 14 July 2023. On 13 October 2026 the entry still read Currently in Shortage: of 90 listed presentations, 56 were available, 33 limited and 1 unavailable.
We have not finished checking this source. No judgement either way. how we score evidence
Caveat on this rating: A dated snapshot of a live database; most presentations were available, and figures will change.
What the FDA's own drug shortage database said about lisdexamfetamine on the day this row was written, and why the date matters.
Significant findings
The FDA drug shortage entry for Lisdexamfetamine Dimesylate Capsule reads "Status: Currently in Shortage", "Date first posted: 07/14/2023", therapeutic category Psychiatry. On 13 October 2026 it listed ten manufacturers, each reverified at a stated date, and 90 product presentations by strength and NDC. 56 were marked available, 33 limited availability and 1 unavailable, with an estimated recovery date given for that one. Reasons recorded under the FDA Safety and Innovation Act included "Shortage of an active ingredient" and "Delay in shipping of the drug"; some suppliers were shipping on allocation.
The other direction
Most presentations were marked available, so a shortage listing does not mean the medicine cannot be found; it means supply of some strengths from some makers is limited. The database is updated as manufacturers report, and each line carries its own reverification date. The figures here are a snapshot and will change. The broader causes are set out in the FDA and DEA's August 2023 joint letter in this library.
What this does not show
It does not say which pharmacy has stock, and it says nothing about the medicine's benefits or risks. It is not a reason to change or stop a medicine; if a strength cannot be filled, the prescriber decides what to do.
Worth asking
If my usual strength is limited, can a different strength or combination give the same dose?
Source
FDA Drug Shortages: Lisdexamfetamine Dimesylate Capsule (Currently in Shortage) — US Food and Drug Administration, Center for Drug Evaluation and Research (2026)
Regulator or national health body
How this was scored
- Study design
- Regulatory safety determination
- Funding
- not recorded
- Published in
- Regulator or national health body
- Sample size
- not recorded
- Preregistered
- not recorded
- Conflicts disclosed
- not recorded
- Independent of proponent
- not recorded
- Retracted
- No
We have not finished checking this source, so there is no scoring to show yet. “We have not checked this yet” and “this is disputed” are different statements, so no scored band is shown rather than a low one.
Read the full scoring rubric, including what it can't tell you.
Published October 21, 2026.
Questions
How strong is the evidence behind this?
veisund rates this source "not yet assessed". We have not finished checking this source. No judgement either way. One caveat travels with that badge: A dated snapshot of a live database; most presentations were available, and figures will change. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
FDA Drug Shortages: Lisdexamfetamine Dimesylate Capsule (Currently in Shortage) — US Food and Drug Administration, Center for Drug Evaluation and Research (2026). Published in: Regulator or national health body. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Regulatory safety determination. Funding: not recorded. Independence from the proponent is not recorded. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.